P5257The anti-cancer tyrosine kinase inhibitor sorafenib reduces cardiac contractile force by reducing cardiomyocyte calcium transient amplitude
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 01
(01)
◽
Keyword(s):
Keyword(s):
2020 ◽
2012 ◽
Vol 55
(11)
◽
pp. 717
◽